🇺🇸 Acetylcystein in United States

255 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 44 reports (17.25%)
  2. General Physical Health Deterioration — 30 reports (11.76%)
  3. Anaemia — 25 reports (9.8%)
  4. Fatigue — 25 reports (9.8%)
  5. Vomiting — 25 reports (9.8%)
  6. Pyrexia — 24 reports (9.41%)
  7. Dizziness — 23 reports (9.02%)
  8. Nausea — 22 reports (8.63%)
  9. Cough — 19 reports (7.45%)
  10. Abdominal Pain — 18 reports (7.06%)

Source database →

Acetylcystein in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Respiratory approved in United States

Frequently asked questions

Is Acetylcystein approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Acetylcystein in United States?

University Hospital, Strasbourg, France is the originator. The local marketing authorisation holder may differ — check the official source linked above.